Divakar Budda
Promovendus/gast
- Naam
- D. Budda
Promovendus/gast
Contact
- Mouraux A., Gousset S., Alvarez B., Baiula M., Bakker W., Bedini A., Bertayli M., Budda D., Carr R., Cuna E., Díaz Ó., Donner N., Giraldo J., Groeneveld G., Gülave B., Guydan D., Hijma H., Maldonado R., Renault P., Rinaudo C., Elaissaiss‐Schaap J., Spiros A., Stoeber S., Takkala P., Valkengoed D.W. van, Hasselt C. van & Lange E.C.M. de (2026), In silico prediction of novel effective combinational treatment of chronic pain in individual patients: a joint white paper of the H2020 QSPainRelief consortium, British Journal of Pharmacology : .
- Budda D., Zhang Z., Hasselt J.G.C. van & Lange E.C.M. de (2025), Beta-endorphin is the key endogenous opioid influencing morphine µ-opioid receptor occupancy in rat hypothalamus: a binding kinetic model analysis, European Journal of Pharmaceutical Sciences 212: 107195.
- Budda D., Gülave B., Hasselt J.G.C. van & Lange E.C.M. de (2024), Non‐linear blood–brain barrier transport and dosing strategies influence receptor occupancy ratios of morphine and its metabolites in pain matrix, British Journal of Pharmacology 181(20): 3856-3868.
- Gülave B., Budda D., Saleh M.A.A.E.W., Hasselt J.G.C. van & Lange E.C.M. de (2023), Does nonlinear blood-brain barrier transport matter for (lower) morphine dosing strategies?, European Journal of Pharmaceutical Sciences 187: 106482.